Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas

  • Authors:
    • In Ah Kim
    • Youn Ju Yang
    • Sei Chul Yoon
    • Ihl Bhong Choi
    • Chul Seung Kay
    • Hee Chung Kwon
    • Chang Min Kim
    • Young Ae Joe
    • Joon-Ki Kang
    • Yong Kil Hong
  • View Affiliations

  • Published online on: November 1, 2001     https://doi.org/10.3892/ijo.19.5.1041
  • Pages: 1041-1047
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated the combined effects of p53 gene transfer and irradiation and its still unclear interaction mechanism in human gliomas. Four human glioma cell lines expressing mutant type p53 (U373 and A172) and wild-type p53 (D54MG and EFC-2) were transfected by adenoviral vectors bearing p53 gene at 50 multiplicity of infection. Two days after transfection, cells were irradiated (3, 6, and 9 Gy). The cytotoxicity was evaluated by clonogenic assay. The quantitative analysis of apoptosis and cell cycle analysis were performed using flow cytometry. Irradiation combined with adenoviral p53 transfection significantly increased cytotoxicity, which was additive in cell lines with wild-type p53 and more than additive in cell lines with mutant p53. The combination of two modalities increased the apoptotic population by 14% in A172 cells and 20% in D54 MG cells, which were the sum of apoptosis from each modality. Adenoviral p53 transfection increased the G1 phase fraction and concomitant decrease of radioresistant S phase fraction in A172 and D54MG cells. Our study demonstrated that p53 gene transfer combined with irradiation increased absolute cytotoxicity in human glioma cells used in this experiment. The interaction mechanism for increased cytotoxicity involved, in part, increased apoptosis and change of cell cycle profile.

Related Articles

Journal Cover

November 2001
Volume 19 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim IA, Yang YJ, Yoon SC, Choi IB, Kay CS, Kwon HC, Kim CM, Joe YA, Kang J, Hong YK, Hong YK, et al: Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas. Int J Oncol 19: 1041-1047, 2001.
APA
Kim, I.A., Yang, Y.J., Yoon, S.C., Choi, I.B., Kay, C.S., Kwon, H.C. ... Hong, Y.K. (2001). Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas. International Journal of Oncology, 19, 1041-1047. https://doi.org/10.3892/ijo.19.5.1041
MLA
Kim, I. A., Yang, Y. J., Yoon, S. C., Choi, I. B., Kay, C. S., Kwon, H. C., Kim, C. M., Joe, Y. A., Kang, J., Hong, Y. K."Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas". International Journal of Oncology 19.5 (2001): 1041-1047.
Chicago
Kim, I. A., Yang, Y. J., Yoon, S. C., Choi, I. B., Kay, C. S., Kwon, H. C., Kim, C. M., Joe, Y. A., Kang, J., Hong, Y. K."Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas". International Journal of Oncology 19, no. 5 (2001): 1041-1047. https://doi.org/10.3892/ijo.19.5.1041